A carregar...
HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development
Clinical progress in the field of HER2-positive breast cancer therapy has been dramatically improved by understanding of the immune regulatory mechanisms of tumor microenvironment. Passive immunotherapy utilizing recombinant monoclonal antibodies (mAbs), particularly trastuzumab and pertuzumab has p...
Na minha lista:
| Publicado no: | Arch Immunol Ther Exp (Warsz) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223380/ https://ncbi.nlm.nih.gov/pubmed/31915932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00005-019-00566-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|